Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1948951000168110 | Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1948961000168112 | Tobi 300 mg/5 mL inhalation solution, 4 x 5 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | Is a | tobramycin 300 mg/5 mL inhalation solution, 4 x 5 mL ampoules | true | Inferred relationship | Some | ||
| Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | has TPUU | Tobi 300 mg/5 mL inhalation solution, 5 mL ampoule | true | Inferred relationship | Some | 1 | |
| Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | has TP | Tobi | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tobi 300 mg/5 mL inhalation solution, 4 x 5 mL ampoules | Is a | True | Tobi (tobramycin 300 mg / 5 mL) inhalation solution, 4 x 5 mL ampoules (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR